Experimental Hematology

Papers
(The TQCC of Experimental Hematology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
3131 – DISPARITIES IN IMMUNOSUPPRESSIVE PROFILES BETWEEN RELAPSED AML WITH OR WITHOUT ALLO-HCT47
3008 – INTEGRATED IN SILICO AND IN VITRO APPROACHES MATCH DEVELOPMENTAL CELL-OF-ORIGIN TO THERAPEUTIC VULNERABILITIES IN INFANT LEUKEMIA37
3127 – INDUCTION OF ONTOGENY-SPECIFIC CD24+ PRELEUKEMIC STEM CELLS IN A KMT2A::AFF1 MURINE MODEL33
3055 – THE 3′ DISTAL ENHANCER REGION OF THE CEBPB GENE IS ESSENTIAL FOR MONOCYTE DEVELOPMENT33
3133 – UNCOVERING DISTINCT METABOLIC PROPERTIES OF RELAPSE AND RELAPSE-FATED CLONES IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA30
2019 – DURING AGEING, THE HEMATOPOIETIC STEM CELL GENOME IS PROTECTED BY DORMANCY, NOT APOPTOSIS.27
3116 – MITOCHONDRIAL FUSION AGONISTS IMPROVE EXPANDED CORD BLOOD HEMATOPOIETIC STEM AND PROGENITOR CELLS FUNCTION IN VIVO26
3016 – MYCT1 CONTROLS HUMAN HEMATOPOIETIC STEM CELL FUNCTION BY MODERATING ENDOCYTOSIS AND ENVIRONMENTAL SENSING25
3059 – UNRAVELLING HUMAN HEMATOPOIETIC PROGENITOR CELL DIVERSITY THROUGH ASSOCIATION WITH INTRINSIC REGULATORY FACTORS24
RNAi Screen Identifies MTA1 as an Epigenetic Modifier of Differentiation Commitment in Human HSPCs21
3064 – ALKBH5 MODULATES HEMATOPOIETIC STEM AND PROGENITOR CELL ENERGY METABOLISM THROUGH M6A MODIFICATION-MEDIATED RNA STABILITY CONTROL19
Corrigendum to A novel lymphoid progenitor cell population (LSKlow) is restricted by p18INK4c Experimental Hematology Volume 44 Issue 9 (2016), 874-885.e519
3033 – DIFFERENTIAL RESPONSES AND RECOVERY DYNAMICS OF HAEMATOPOIETIC POPULATIONS FOLLOWING PLASMODIUM CHABAUDI INFECTION19
1022 – ADVANCES IN CELLULAR BARCODING: EXPLORING HEMATOPOIETIC STEM CELLS AGEING AND METABOLIC FUNCTIONS IN LINEAGE SPECIFICATION18
1007 – GENOMIC REPETITIVE ELEMENTS SIGNAL SURFACE B2M TO BLOCK PHAGOCYTOSIS OF HSCS18
IFC Editorial Board17
3194 – CLONAL HEMATOPOIESIS-ASSOCIATED DNMT3A MUTATIONS CAUSE INCREASED T CELL ACTIVATION AND DECREASED LEUKEMIC TUMOR BURDEN16
1030 – CELLULAR AND MOLECULAR MECHANISMS OF HEMATOPOIETIC LINEAGE CHOICE16
3215 – TWO NOVEL ENHANCERS OF CDKN1A ARE EPIGENETICALLY REGULATED BY THE CHROMATIN ASSEMBLY FACTOR 1 AND CEBPA IN ACUTE MYELOID LEUKEMIA16
3060 – BONE MARROW MESENCHYMAL STEM CELLS RELY ON VASCULAR CELL ADHESION MOLECULE-1 FOR SURVIVAL AND NICHE MAINTENANCE15
RNA methylation: where to from here for hematologic malignancies?14
Notch1 activation and inhibition in T-cell acute lymphoblastic leukemia subtypes14
Dynamics of human hematopoietic stem and progenitor cell differentiation to the erythroid lineage14
Distinct transcriptional changes in hematopoietic progenitor subsets on LPS-induced emergency granulopoiesis14
CD20-targeted immunotherapies in B-cell malignancies: mechanistic and clinical advances13
3185 – A MACHINE LEARNING PIPELINE UNCOVERS LAG-3-MEDIATED IMMUNOREGULATION IN INFLAMMATORY HSCs13
Neutrophil death-more than meets the eye13
3144 – GRX1 DEGLUTATHIONYLATES NF-κB P65 TO INCREASE LAG3 EXPRESSION IN T CELLS AND PROMOTE TUMOR GROWTH13
Corrigendum to ’ 5-Aza-dC promotes T-cell acute lymphoblastic leukemia cell invasion via downregulation of DNMT1 and upregulation of MMP-2 and MMP-9’ [Volume 114, October 2022, Pages 43-53.e2]13
3218 – LYL1 IS CRITICAL FOR ADULT HEMATOPOIETIC STEM CELL-DERIVED B- AND T-LYMPHOPOIESIS13
3129 – PREEMPTIVE TARGETING OF PRELEUKEMIC CELLS IN DOWN SYNDROME WITH PATHWAY-DIRECTED THERAPIES: A NOVEL APPROACH TO PREVENT MYELOID LEUKEMIA12
3138 – LIMS1 REGULATES ACUTE MYELOID LEUKEMIA INITIATION THROUGH CELL ADHESION INTERACTIONS AND MIGRATION OF LEUKEMIC STEM CELLS12
3085 – THERMAL PROTEOME IDENTIFIES KEY REGULATORS IN HEMATOPOIETIC STEM CELLS12
2015 – MENIN ORCHESTRATES EXPRESSION OF THE MASTER PLASMA CELL TRANSCRIPTION FACTOR IRF4 AND IS AN ACTIONABLE TARGET IN MULTIPLE MYELOMA.12
3089 – AN ITGB3 CYTOPLASMIC MUTATION CAUSES MACROTHROMBOCYTOPENIA VIA IMPAIRED αIIBβ3–RHOA SIGNALING11
1005 – MAPPING THE DEVELOPMENTAL PATHWAYS TO HUMAN HEMATOPOIETIC AND LEUKEMIC STEM CELLS11
3004 – IN VITRO EXPANDED HEMATOPOIETIC STEM CELLS COMBINED WITH NON-GENOTOXIC CONDITIONING ENABLE EFFICIENT TRANSPLANTATION AND SUPPRESS MYELOID DISEASE11
3187 – MECOM PROMOTES LEUKEMIA PROGRESSION AND INHIBITS MAST CELL DIFFERENTIATION THROUGH FUNCTIONAL COMPETITION WITH GATA211
1006 – HEMATOPOIETIC STEM CELL ACTIVATION FOR BLOOD REGENERATION11
Gene regulatory complexes: their role and regulation across normal and malignant hematopoiesis10
3110 – EGFL7 IS IMPORTANT FOR CELL CYCLE REGULATION AND PROLIFERATION OF HSCS10
Effect of peritransplant measurable residual disease clearance in patients with myelodysplastic neoplasm: a referral center experience10
JQ-1/bortezomib combination strongly impairs MM and PEL survival by inhibiting c-Myc and mTOR despite the activation of prosurvival mechanisms10
3220 – THE BONE MARROW EXTRACELLULAR MATRIX REMODELLING DURING ACUTE MYELOID LEUKAEMIA10
3192 – DEFINING THE MECHANISMS OF BST2 IN INFLAMMATION-DEPENDENT HEMATOPOIETIC STEM CELL ACTIVATION9
3141 – METABOLIC PROFILING OF HEMATOPOIETIC STEM CELLS (HSCS) FOLLOWING ACUTE INFLAMMATION9
3069 – EXPANSION OF A NOVEL LEUKEMIA STEM CELL-SUPPORTING CD55+ FIBROBLAST POPULATION IN THE PRELEUKEMIC BONE MARROW9
3131 – CROSS-SPECIES TRANSCRIPTOMICS REVEALS BIFURCATION POINT DURING THE ARTERIAL-TO-HEMOGENIC TRANSITION9
2004 – INFLAMMATORY FACTORS ORCHESTRATE THE BIRTH OF HSPCS THROUGH THEIR OSCILLATORY SIGNALING DYNAMICS9
3174 – DOWNREGULATION OF MITOCHONDRIAL COMPLEX II IN MYELODYSPLASTIC SYNDROMES9
2016 – CD32 ALLOWS CAPTURING BLOOD CELLS EMERGENCE IN SLOW MOTION DURING HUMAN EMBRYONIC DEVELOPMENT9
3055 – MULTI-OMICS REVEALS AZACITIDINE PARTIALLY RESTORES THE HEMATOPOIESIS-SUPPORTIVE FUNCTIONS IN MESENCHYMAL STROMAL CELLS FROM PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA9
A new era of functional experimentation in human hematopoiesis and leukemia research9
3124 – ANALYSIS OF TRANSCRIPTOMIC AND EPITRANSCRIPTOMIC EFFECTS OF THE ACUTE MEGAKARYOBLASTIC LEUKEMIA FUSION PROTEIN RBM15-MKL19
2024 – UNDERSTANDING HOW THE TISSUE MICROENVIRONMENT DIRECTS CELL FATE IN HAEMATOPOIETIC STEM AND PROGENITOR CELLS9
3054 – MESENCHYMAL STEM CELLS REVERSIBLY DE-DIFFERENTIATE MYOFIBROBLASTS TO FIBROBLAST-LIKE CELLS BY INHIBITING THE TGF-Β-SMAD2/3 PATHWAY9
Current landscape of mRNA therapeutics for acute myeloid leukemia8
Endogenous small molecule effectors in GATA transcription factor mechanisms governing biological and pathological processes8
ZC3H13 facilitates the progression of acute myeloid leukemia through m6A-FOXP1-mediated metabolic reprogramming8
Splicing the Difference: Harnessing the Complexity of the Transcriptome in Hematopoiesis8
Reassessment of Hematopoietic Stem Cell Aging through Metabolic Uncoupling and Mitochondrial Resilience8
Reproducibility of low-level residual myeloma immunoglobulin detection using ultra-deep sequencing8
Prognostic significance of myeloid-derived suppressor cells and systemic inflammation in newly diagnosed diffuse large B cell lymphoma treated with chemoimmunotherapy8
Building bones for blood and beyond: the growing field of bone marrow niche model development7
3011 – UNIQUE ROLES OF KMT2A FAMILY MEMBERS IN HEMATOPOIESIS AND LEUKEMIA7
3043 – FETAL EMERGENCY MYELOPOIESIS IS RESTRICTED BY MATERNAL INFLAMMATION.7
3168 – TARGETING JAK1 SIGNALING FOR MOLECULAR PREVENTION IN CLONAL HEMATOPOIESIS7
Serum cholesterol levels demonstrate dynamic changes following autologous hematopoietic stem cell transplantation in patients with multiple myeloma7
2008 – SELF-RENEWAL OF LATE-STAGE ERYTHROID PROGENITORS7
3108 – PHOSPHORYLATION OF RUNX1 PROMOTES MEGAKARYOCYTIC FATE IN MEGAKARYOCYTE-ERYTHROID PROGENITOR FATE SPECIFICATION7
Ontogeny, dynamics, and characteristics of neutrophils during the perinatal period7
3057 – MULTIOME ANALYSIS IDENTIFIES HSC SUBSETS WITH THYMIC REGENERATIVE CAPACITY7
3097 – THE LONG NONCODING RNA ELDR AS A NEW THERAPEUTIC TOOL AGAINST HUMAN ACUTE MYELOID LEUKEMIA (AML)7
3073 – EARLY IDENTIFICATION OF STEROID-REFRACTORY GRAFT-VERSUS-HOST DISEASE BY F-DEX ASSAY AND MURINE MODELS7
3052 – PLZF LOSS-OF-FUNCTION ALTERS THE HEMATOPOIETIC STEM CELL COMPARTMENT IN AN AGE-DEPENDENT MANNER6
2006 – RAS MUTATIONS TRANSFORM GRANULOCYTE-MONOCYTE PROGENITORS INTO INFLAMMATORY LEUKEMIA STEM CELLS IN ACUTE MYELOID LEUKEMIA6
3110 – EX VIVO CRISPR-BASED SICKLE CELL MODELING6
Ubiquitin E3 ligase FBXO21 regulates cytokine-mediated signaling pathways, but is dispensable for steady-state hematopoiesis6
3163 – ANTI-CD69 MONOCLONAL ANTIBODY AVENUE DISEASE PROGRESSION IN A MOUSE MODEL OF CHRONIC MYELOMONOCYTIC LEUKEMIA WITH NRASG12D MUTATION6
3193 – THE FUNCTIONAL ROLE OF NUCLEAR PROTEIN 1 (NUPR1) IN AGE-RELATED HEMATOPOIETIC STEM CELL FATE PRIMING6
3190 – ACCOUNTING FOR BIOLOGICAL VARIATION IN SCRNA-SEQ QUALITY CONTROL METRICS RETAINS DISTINCT NICHE AND HEMATOPOIETIC CELL TYPES6
3042 – PRECISE INTRODUCTION OF SRSF2 P95H RECAPITULATES DISEASE PHENOTYPES AND GIVES INSIGHT INTO THE CELLULAR MECHANISM OF ACTION6
3187 – INVESTIGATION OF THE THERAPEUTIC EFFECT OF A NOVEL SMALL MOLECULE INHIBITING YBX1 IN MYELOID MALIGNANCIES6
3151 – PUTTING THE STING BACK INTO THERAPY FOR P53 MUTANT BLOOD CANCERS6
3027 – CASEIN KINASE II ALPHA (CK2A) DELETION AFFECTS MYELOID HEMATOPOIESIS IN CONDITIONAL KNOCKOUT MOUSE MODEL6
Preconditioning intervention prior to allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia6
Immune control in acute myeloid leukemia5
3082 – SECRETOMIC CHARACTERIZATION OF REVITALIZED BONE MARROW STROMAL CELLS IDENTIFIES SEMAPHORIN 3A AS A NICHE FACTOR THAT REGULATES HSC QUIESCENCE5
1024 – NICOTINAMIDE RIBOSIDE ENHANCES AMINO ACID CATABOLISM TO REJUVENATE OLD HEMATOPOIETIC STEM CELLS BY RESTORING THEIR METABOLISM AND PROTEOSTASIS5
Avatrombopag is effective in patients with chemoradiotherapy-induced aplastic anemia: a single-center, retrospective study5
Analysis of risk factors for early death of lymphocyte subsets in adult patients with secondary hemophagocytic lymphohistiocytosis5
C-COUNT: a convolutional neural network–based tool for automated scoring of erythroid colonies5
3021 – EX VIVO EXPANSION OF HEMATOPOIETIC PROGENITOR CELLS DERIVED FROM INDUCED PLURIPOTENT STEM CELLS5
Effect of Clonal Hematopoiesis on Cardiovascular Disease in People Living with HIV5
Development and aging of resident endothelial stem cells in pre-existing blood vessels5
1002 – BONE MARROW FAILURE AND CLONAL EVOLUTION5
TET2 loss enhances early response to inflammation in primitive and committed myeloid cells5
Hematopoietic stem cell senescence and opportunities for intervention5
Inflammation-related mRNA expression in patients with multiple myeloma undergoing hematopoietic stem cell mobilization5
3076 – EARLY MYELOID COMMITMENT OF HSCS: MAFB AS A MASTER REGULATOR?5
3180 – SRSF2 P95H AND NF1 DEFICIENCY SYNERGIZE TO PROMOTE MYELOID-BIASED CLONAL HEMATOPOIESIS FROM HEMATOPOIETIC STEM CELLS VIA JAK-STAT ACTIVATION IN MICE5
Glucose-6-phosphate dehydrogenase is dispensable for human erythroid cell differentiation in vitro5
Inhibition of PAK1 generates an ameliorative effect on MPLW515L mouse model of myeloproliferative neoplasms by regulating the differentiation and survival of megakaryocytes5
Generation of functionally distinct hemogenic endothelial cell populations from pluripotent stem cells5
3128 – IDENTIFICATION AND CHARACTERIZATION OF CD96+CD70+ LEUKEMIC STEM CELLS AND NICHE-MEDIATED RESISTANCE IN CBFA2T3-GLIS2 AMKL5
In Memoriam: Prof. Vittorio Rizzoli, The visionary who built experimental hematology in Italy5
3097 – CLONAL COMPETITION, FITNESS, AND MUTATION TIMING DRIVE ADVERSE OUTCOMES IN CLONAL HEMATOPOIESIS5
1024 – A GENETIC LABELING STRATEGY FOR COMPETITIVE XENOTRANSPLANTATION OF HUMAN HSCS5
3044 – IDENTIFICATION OF SURFACE MARKERS OF MALIGNANT CELL STATES IN ACUTE MYELOID LEUKEMIA USING EXPLAINABLE MACHINE LEARNING4
3029 – ISOFORM SPECIFIC ROLES FOR CD97 IN ACUTE MYELOID LEUKEMIA4
3122 – CUX1 LEVELS CONTROL HEMATOPOIETIC STEM CELL FATE AND PLASTICITY4
3120 – INVESTIGATING THE ROLE OF GPR56 IN ACUTE MYELOID LEUKAEMIA USING A TET-ON MODEL OF AN ACTIVATED GPR56 RECEPTOR IN HUMAN IPSC-DERIVED HAEMATOPOIETIC CELLS4
3173 – HAPLODEFICIENCY OF THE MTAP/CDKN2 LOCUS DRIVES IMMUNOMETABOLIC DYSREGULATION AND STROMAL CELL ALTERATIONS LEADING TO MYELODYSPLASTIC SYNDROMES-LIKE DISEASE4
1032 – STEM CELLS IN HUMAN AML4
3198 – IGH TRANSLOCATIONS IN CHINESE PATIENTS WITH CHRONIC LYMPHOCYTICLEUKEMIA: CLINICOPATHOLOGIC CHARACTERISTICS AND GENETIC PROFILE4
1004 – REGULATION OF THE HEMATOPOIETIC STEM CELL POOL BY C-KIT-ASSOCIATED TROGOCYTOSIS4
3221 – KLF4/MLL3 CAMPASS COMPLEX TRANSCRIPT REGULATING NRBP2 TO ELIMINATE AML CELLS4
1008 – UNIFIED SINGLE-CELL METHODS SORT DIVERGENT FATES THROUGH GENE REGULATION4
Functional and molecular profiling of hematopoietic stem cells during regeneration4
3109 – IDENTIFICATION OF B LINEAGE COMMITMENT MARKERS FOR GENE EXPRESSION-BASED RISK STRATIFICATION OF INFANT KMT2A::AFF1 ACUTE LYMPHOBLASTIC LEUKEMIA4
Complementary and countervailing actions of Jak2 and Ikk2 in hematopoiesis in mice4
Characterization of Human Engraftment and Hemophagocytic Lymphohistiocytosis in NSG-SGM3 Neonate Mice Engrafted with Purified CD34+ Hematopoietic Stem Cells4
3119 – IDENTIFICATION OF CULTURE CONDITIONS THAT SUSTAIN THE IN VIVO REGENERATIVE PROPERTIES OF A NEW SUBSET OF HUMAN FETAL LIVER HEMATOPOIETIC STEM CELLS4
3076 – CHARACTERIZATION OF THE ROLE OF EIF4A IN THE RESISTANCE OF ACUTE MYELOID LEUKEMIA TO CHEMOTHERAPY AND TARGETED THERAPIES4
3012 – DEEPLY QUIESCENT HEMATOPOIETIC STEM CELLS MAINTAIN FUNCTION BY GPRASP2-MEDIATED CELL-SURFACE RECEPTOR DEGRADATION4
3018 – DETERMINING THE VARIATIONS OF THE NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IN CANCER PATIENTS - A PROSPECTIVE STUDY4
2023 – INTRA- AND EXTRACELLULAR PROTEOME DYNAMICS DURING NORMAL AND MALIGNANT HEMATOPOIETIC STEM CELL EXPANSION4
2004 – A SINGLE-CELL PROTEOMICS BY MASS SPECTROMETRY BASED MAP OF THE HUMAN CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELL COMPARTMENT4
3003 – MASS SPECTROMETRY-BASED PROFILING OF BONE MARROW NICHE SECRETOME REMODELING IN AGING AND TET2-MUTANT CLONAL HEMATOPOIESIS4
3136 – RAMAN SPECTROSCOPY IMAGING TO TRACK ACTIVITY OF IMMUNE CELLS.4
3213 – DISSECTING THE BLOOD ECOSYSTEM IN SARS-COV-2 OMICRON PATIENTS4
TAZ downregulated ANXA1 expression to modulate myeloma cell interactions with bone marrow mesenchymal stromal cells4
3086 – THE ROLE OF DEVELOPMENTAL WNT SIGNALING IN ABERRANT ADULT HEMATOPOIESIS4
2011 – SUBCLONAL MUTATIONS ALTER CORE SIGNALLING NODES AND DRUG RESPONSES IN PAEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA4
1016 – FINE-TUNING TPO-MPL ACTIVITY TO CONTROL HEMATOPOIESIS4
Effects of ruxolitinib on murine regulatory T cells are immune-context dependent4
IFC Editorial Board3
2012 – DENDRITIC CELLS IN DEVELOPING AND ADULT ZEBRAFISH ARISE FROM DIFFERENT ORIGINS AND DISPLAY DISTINCT FLT3 DEPENDENCIES3
3001 – PCYT1A IS A METABOLIC VULNERABILITY IN MONOCYTIC ACUTE MYELOID LEUKEMIA3
1007 – MAXIMIZING CELL DEATH IN LEUKEMIAS: BCL-2 AND BEYOND3
3018 – THE BILE ACID RECEPTOR TGR5 REGULATES THE COMPOSITION AND HEMATOPOIETIC SUPPORT CAPACITY OF THE BONE MARROW MICROENVIRONMENT3
AKT2 inhibition accelerates the acquisition of phagocytic ability in induced pluripotent stem cell–derived neutrophils3
Highlighting the contributions of Professor T. Ray Bradley to ISEH and the field of Experimental Hematology3
3177 – RUNX FACTORS LAUNCH T CELL AND INNATE LYMPHOID CELL PROGRAMS VIA DIRECT BINDING AND GENE NETWORK-BASED MECHANISMS3
2024 – A STEP-WISE AND DETERMINISTIC LEUKEMIA MOUSE MODEL REMINISCENT OF JMML WITH ENDOGENOUS ACQUISITION OF PATIENT-RELEVANT RTK–RAS MUTATIONS3
3075 – DNMT3A LIMITS MYELOID SIGNALING RESPONSES IN T-CELL PROGENITORS DURING NORMAL AND LEUKEMIC DEVELOPMENT3
3171 – GLYCOLYSIS DRIVES IL-6 PRODUCTION BY BONE MARROW STROMAL CELLS DURING ACUTE INFLAMMATION3
3048 – DISSECTING THE HETEROGENEITY OF EX VIVO EXPANDED HEMATOPOIETIC STEM AND PROGENITOR CELLS WITH MICRORNAS3
3246 – DEVELOPMENTAL AND FUNCTIONAL ANALYSIS OF MONOCYTES AND MACROPHAGES IN ZEBRAFISH DURING HEART REGENERATION3
3056 – DNMT3A MUTATIONS UPREGULATE CELL ADHESION MOLECULES TO PROMOTE INVASIVENESS OF T-ALL CELLS3
Assay optimization for the objective quantification of human multilineage colony-forming units3
MYC unchained: dosage-dependent locking of the myeloid fate (or not)3
3201 – HEMATOPOIETIC STEM CELL-DERIVED CAR-IMMUNE SYSTEM FOR TUMOR IMMUNOTHERAPY3
Mtg16 NHR1 mutations cause defects in lymphopoiesis and the response to anemia3
3177 – CLONAL HEMATOPOIESIS PROMOTES HEART FAILURE WITH PRESERVED EJECTION FRACTION3
1005 – SWITCHING GENES ON AND OFF DURING HAEMATOPOIESIS3
3036 – AUTOPHAGY REGULATES THE MATURATION OF HEMATOPOIETIC PRECURSORS IN THE EMBRYO3
3027 – IDENTIFYING PIONEER FACTORS DURING HEMATOPOIETIC STEM CELL EMERGENCE3
3178 – FANCONI ANEMIA PROTEIN FANCD2 REGULATES FETAL LIVER HEMATOPOIETIC STEM CELL EXPANSION IN A CELL-INTRINSIC AND EXTRINSIC MANNER3
2023 – CELLULAR BARCODING OF THE LEUKEMIC NICHE REVEALS AN APELIN-MEDIATED CLONAL EXPANSION OF NICHE ENDOTHELIAL AND MESENCHYMAL STROMAL CELLS3
3151 – THE ALTERNATIVE NUCLEOSOME REMODELING FACTOR COMPLEX SUSTAINS ACUTE MYELOID LEUKEMIA BY REGULATING THE ACCESSIBILITY OF INSULATOR REGIONS3
Trained immunity and epigenetic memory in long-term self-renewing hematopoietic cells3
Sustained MYC overexpression drives myeloid differentiation block and acquisition of leukemic phenotypes3
Fetal allotransplant recipients are resistant to graft-versus-host disease3
Cover 2: Editorial Board3
3068 – N-MYC EXPRESSION IS NEGATIVELY CORRELATED WITH SELF-RENEWAL POTENTIAL IN HSCS3
1018 – MALPS: A MASTER REGULATOR OF BONE MARROW MICROENVIRONMENT3
2009 – WORLD TRADE CENTER 9/11 DISASTER EXPOSURE IS ASSOCIATED WITH CLONAL HEMATOPOIESIS IN FIRST RESPONDERS AND IS CHARACTERIZED BY INNATE IMMUNE INFLAMMATION.2
3200 – RENIN-ANGIOTENSIN SYSTEM INHIBITORS SUPPRESS THE GROWTH OF LEUKEMIA CELLS2
3150 – GATA2 DETERMINES HEMATOPOIETIC STEM/PROGENITOR CELL RESPONSES TO OPPORTUNISTIC FUNGAL INFECTION2
1012 – DEVELOPMENTAL PROGRAMMING OF TISSUE-RESIDENT MACROPHAGES2
3023 – CHARACTERIZATION OF THE ONCOGENIC ACTIVITY OF TLX1 AND TLX3 TRANSCRIPTION COMPLEXES IN T-ALL2
3158 – VENETOCLAX AND PROTEASOME INHIBITORS SYNERGISTICALLY INDUCE APOPTOSIS IN ACUTE MYELOID LEUKEMIA2
Efficacy and safety of avatrombopag in combination with standard immunosuppressive therapy for severe aplastic anemia2
3235 – HYPERDIPLOIDY IMPAIRS FETAL HSPC FITNESS AND DIFFERENTIATION ENABLING LONG-TERM PERSISTENCE OF RARE PRELEUKEMIC TRISOMIC CLONES IN BONE MARROW2
3106 – PROTEOMICS AND GENOMICS STUDIES REVEALED A NEW ROLE FOR MLL PARTIAL TANDEM DUPLICATION (PTD) IN MYELODYSPLASTIC SYNDROME (MDS) AND ACUTE MYELOID LEUKEMIA (AML)2
Cover 2: Editorial Board2
Cohesin haploinsufficiency is tolerated in Cbfb::MYH11-driven murine acute myeloid leukemia2
Cell-extrinsic factors contribute toward myeloid-biased expansion in Tet2-mutant clonal hematopoiesis2
3064 – AN ACTIVATED GPR56 RECEPTOR ENHANCES SURVIVAL OF HUMAN IPSC-DERIVED HAEMATOPOIETIC STEM/PROGENITOR CELLS2
3179 – ID1 ABLATION RESCUES CLONAL HEMATOPOIESIS AND DELAYS DISEASE PROGRESSION IN TET2 NULL MICE2
1029 – ETIOLOGY, PATHOGENESIS AND CELL-OF-ORIGIN OF MLL-REARRANGED INFANT/PEDIATRIC B-CELL ALL2
2019 – ENDOTHELIAL CELL-DERIVED THROMBOSPONDIN-1 NEGATIVELY AFFECTS HEMATOPOIETIC FUNCTION DURING AGING2
3068 – CRISPR SCREENING IN PRIMARY HUMAN CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS IDENTIFIES THE RNA HELICASE DDX6 AS A NOVEL HSC REGULATOR2
1022 – THE DEVELOPMENTAL ORIGINS OF BLOOD AND BLOOD CANCER2
3247 – A PROMISING PLANT ALKALOID PROVIDES NEUROPROTECTION AGAINST AΒ-INDUCED TOXICITY IN SH-SY5Y CELLS2
3095 – SEX-SPECIFIC DIFFERENCES IN PLATELET PARAMETERS AND THE UTILITY OF MEAN PLATELET VOLUME/ PLATELET COUNT RATIO IN DIAGNOSING IRON DEFICIENCY ANEMIA2
3007 – T-CELL MEDIATED STEM-LIKE PLASTICITY OF GERMINAL CENTER B CELLS2
3202 – M. AVIUM INDUCES EPIGENETIC REPROGRAMMED HSPC-TRAINED IMMUNITY THAT ALTERS DOWNSTREAM MYELOID IMMUNE FUNCTION.2
IFC Editorial Board2
A-to-I RNA editing and hematopoiesis2
Differences in the mutational landscape of clonal hematopoiesis of indeterminate potential among races and between male and female patients with cancer2
3047 – A NAD+ METABOLIC CHECKPOINT REGULATES HEMATOPOIETIC STEM CELL ACTIVATION AND AGING2
3111 – BCL11B ORCHESTRATES GENERATION OF LYMPHOID-PRIMED DEFINITIVE HEMATOPOIETIC PROGENITORS FROM HUMAN INDUCED PLURIPOTENT STEM CELLS2
2022 – TRANSCRIPTION FACTOR REDISTRIBUTORS ACTUATE NON-CANONICAL GENE CIRCUITS TO DRIVE AML DIFFERENTIATION2
3089 – ERK INHIBITORS SUPPRESS THE GROWTH OF LEUKEMIA CELLS2
1011 – MULTIPLEXING SPATIAL TRANSCRIPTOMICS, 4D IN SITU INTRAVITAL DATA AND 3D IMAGING TO DEFINE BONE MARROW MICROENVIRONMENTS IN INFLAMMATION AND BLOOD CANCER2
3145 – SINGLE-CELL RNA SEQUENCING REVEALS GATA3 REGULATES DIFFERENTIATION OF REGULATORY T CELLS IN AML2
3099 – CYTOPLASMIC LOCALIZATION OF THE POLYCOMB PROTEIN CBX7 BLOCKS LEUKEMIC CELL GROWTH.2
3139 – THE ROLE OF MYELOID CELLS HARBORING CLONAL HEMATOPOIESIS MUTATIONS IN ALZHEIMER'S DISEASE2
1019 –2
3148 – EMP- AND HSC-DERIVED NEUTROPHILS DYNAMICALLY CONTRIBUTE TO THE DEVELOPING MOUSE HEMATOPOIETIC SYSTEM2
Novel techniques to quantitatively assess age-dependent alterations in biophysical properties of HSPCs and bone marrow niche2
Transcriptional and functional consequences of Oncostatin M signaling on young Dnmt3a-mutant hematopoietic stem cells2
3005 – DIFFERENTIATION, AGING, AND LEUKEMIA ALTER THE METABOLIC PROFILE OF HUMAN BONE MARROW HEMATOPOIETIC STEM AND PROGENITOR CELLS1
3110 – IDENTIFYING DISEASE-MODIFYING THERAPIES IN MYELOPROLIFERATIVE NEOPLASMS1
A xeno-free red blood cell differentiation formula models sickle cell disease from somatically sourced patient iPSCs1
2024 – SPATIAL TRANSCRIPTOMICS CHARACTERIZE DYNAMIC AND POLARIZED NICHE CELLS AND SIGNALS FOR EMBRYONIC HEMATOPOIESIS1
3044 – CRISPR ACTIVATION SCREENS IDENTIFY CO-DRIVERS OF MALIGNANT HAEMATOPOIESIS IN A DNMT3A MUTANT BACKGROUND1
IFC Editorial Board1
3200 – DEVELOPMENTAL REGULATION OF ENDOTHELIAL-TO-HEMATOPOIETIC TRANSITION FROM INDUCED PLURIPOTENT STEM CELLS1
Lethal and sublethal effects of programmed cell death pathways on hematopoietic stem cells1
The (intra-aortic) hematopoietic cluster cocktail: what is in the mix?1
3118 – CHAPERONE-MEDIATED AUTOPHAGY MAINTAINS LEUKEMIC STEM CELLS1
2002 – EXPEDITED MONOCYTE-INDEPENDENT MACROPHAGE DIFFERENTIATION FROM A DEVELOPMENTALLY RESTRICTED HUMAN DEFINITIVE HEMATOPOIETIC STEM CELL1
3038 – SCIMP PROMOTES TLR SIGNALING AND REGULATES FUNCTION IN HEMATOPOIETIC STEM CELLS1
3040 – IDENTIFYING NOVEL REGULATORY MECHANISMS AT THE ZETA GLOBIN LOCUS USING HUMAN MODELS OF HEREDITARY PERSISTENCE OF EMBRYONIC GLOBIN1
3002 – TRANSCRIPTION FACTOR PROFILING REVEALS THAT CEBPA PROMOTES RIBOSOMAL RNA SYNTHESIS IN MYELOID PROGENITORS1
3137 – HEMATOPOIETIC STEM AND PROGENITOR CELLS IN MYELODYSPLASTIC SYNDROMES (MDS): STUDIES OF PRE-MDS AND MDS IN MOUSE MODELS REVEAL DISTINCT HSPC PHENOTYPES1
3024 – DEVELOPMENTAL DIFFERENCES IN CHROMATIN-LEVEL LINEAGE PRIMING AND PROMISCUITY WITHIN THE HEMATOPOIETIC STEM AND PROGENITOR COMPARTMENT1
3116 – THE ROLE OF THE DACH FAMILY OF NUCLEAR PROTEINS IN KMT2A-AFF1 ASSOCIATED INFANT LEUKEMIA1
Peposertib suppresses generation of FLT3-internal tandem duplication formed by contralateral double nicks1
2001 – BLOOD FLOW TRIGGERS MTORC1-DEPENDENT MITOCHONDRIAL REMODELING REQUIRED FOR HEMATOPOIETIC STEM CELL FATE1
2015 – STRUCTURAL AND FUNCTIONAL ANALYSIS OF BONE MARROW STROMAL NETWORKS DURING CHEMOTHERAPY1
3201 – MOLECULAR CHARACTERISTICS OF MALIGNANT HEMATOPOIETIC STEM CELLS IN ESSENTIAL THROMBOCYTHEMIA ACROSS DISTINCT DRIVER MUTATIONS1
3221 – NFAT TRANSCRIPTION FACTORS ARE REQUIRED FOR DEFINITIVE HEMATOPOIESIS1
3104 – EARLY MOLECULAR STEPS IN HUMAN BONE MARROW STEM CELL DIFFERENTIATION TRAJECTORIES1
Metabolic regulation of erythrocyte development and disorders1
IFC Editorial Board1
3047 – ROLE OF EPIGENETIC DYSFUNCTION IN CHRONIC NEUTROPHILIC LEUKEMIA1
Honoring giants in hematopoietic stem and progenitor cell biology1
3175 – AN UNSUPERVISED INTEGRATION FRAMEWORK TO COMPREHENSIVELY CAPTURE HUMAN HEMATOPOIETIC STEM CELL VARIATION IDENTIFIES HALLMARK SIGNATURES WITH A LINK TO AGING1
3211 – DEVELOPMENT OF UNIVERSAL OFF-THE-SHELF T-CELL MEDICINE PRODUCED FROM PLURIPOTENT STEM CELLS FOR THE TREATMENT OF COVID-191
3156 – TARGETING EIF4A ERADICATES ACUTE MYELOID LEUKEMIA IN A VENETOCLAX-TREATED PDX MODEL DRIVEN BY MUTANT FLT31
3149 – PROGNOSTIC IMPLICATIONS OF FATTY ACID METABOLISM GENES IN PEDIATRIC B-CELL ALL WITH HIGH VDAC EXPRESSION: A TRANSCRIPTOMIC ANALYSIS1
2020 – PRECISE SINGLE-CELL TRANSCRIPTOMIC MAPPING OF NORMAL AND LEUKEMIC CELL STATES REVEALS UNCONVENTIONAL LINEAGE PRIMING IN ACUTE MYELOID LEUKEMIA1
3195 – FISH IN COMBINATION WITH RT-PCR AIDS IN THE CLASSIFICATION OF B-OTHER ALL BY IMPROVING THE IDENTIFICATION OF THE ZNF384 REARRANGEMENT1
3043 – SEX-DEPENDENT NICHE RESPONSES MODULATE STEADY-STATE AND REGENERATIVE HEMATOPOIESIS1
Harnessing the potential of gene-editing technology to overcome the current bottlenecks of CAR-T cell therapy in T-cell malignancies1
3145 – WHAT IS THE FUNCTION OF THE EPO-EPOR AXIS IN MATURE XENOPUS ERYTHROCYTES?1
3062 – HIGH THROUGHPUT EPIGENOMIC PROFILING IN HEMATOPOIETIC STEM/PROGENITOR FATE COMMITMENT1
D816V KIT mutation induces mitochondrial morphologic and functional changes through BNIP3 downregulation in human myeloid cell lines ROSA and TF-11
From γ to X: same destination but different journey?1
3143 – ACUTE HEMATOPOIETIC RESPONSE OF GRANULOCYTE COLONY-STIMULATING FACTOR EXPRESSION IN MEDAKA FISH1
3082 – THE EPCR/PAR1 SIGNALING IN HEMATOPOIETIC STEM CELLS1
3015 – COORDINATED REGULATION AT THE SYSTEMIC AND LOCAL LEVELS PLAYS A PIVOTAL ROLE IN DETERMINING HEMATOPOIETIC STEM CELL NUMBERS1
3030 – NICHE INTERACTIONS DURING DEVELOPMENT DOWNREGULATE INFLAMMATORY PATHWAYS IN HEMATOPOIETIC STEM AND PROGENITOR CELLS1
3086 – APOPTOTIC CELLS-DERIVED CD14(+) MICROPARTICLES PROMOTE THE PHAGOCYTIC ACTIVITY OF NEUTROPHILIC PRECURSOR CELLS IN THE PHAGOCYTOSIS OF APOPTOTIC CELLS1
3007 – HSPCS DIFFERENTIATE TO A DIVERSE SET OF LYMPHOID LINEAGE IMMUNE CELLS DURING DEVELOPMENT1
3205 – FROM CODONS TO BLOOD: A NEW PERSPECTIVE ON HEMATOPOIETIC DIFFERENTIATION1
0.32539200782776